Rewind Therapeutics

Rewind Therapeutics

04 Jan 2018
€15,200,000
Venture capital (Series A)
Boehringer Ingelheim Venture Fund, ParticipatieMaatschappij Vlaanderen, Merck Ventures BV, +2

| Belgian biotech company Rewind Therapeutics picks up Series A funding

PE Hub